Matthew Weiss

Matthew Weiss currently serves as Executive Director and Head of Medicinal Chemistry at Kymera Therapeutics, a position held since January 2018, following a progression through several senior roles within the company. Prior to joining Kymera Therapeutics, Matthew Weiss worked at Amgen for over 14 years, where roles included Principal Scientist and Senior Scientist. Earlier career experience includes a postdoctoral fellowship at UC Irvine. Matthew Weiss earned a Ph.D. in Chemistry from Yale University and a Bachelor of Science in Chemistry from Bowdoin College.